Several genes are associated with age-related conditions, including hearing loss, retinal degeneration and osteoarthritis, a large screening programme in the UK has identified.
The animal study, published in'Nature Communications' this week, may lead to studies of the equivalent human gene and help develop screening programmes to identify the risk of developing an age-related condition many years before symptoms appear.
"Our study is an important springboard for a better understanding of which genes in humans are involved in age-related conditions and how changes in those genes influence this. This is a first and vital step in developing new therapies," said Lead researcher, Dr Paul Potter of Medical Research Council (MRC) Harwell.
"As we get older, we have an increased risk of developing many conditions, including diabetes, cardiovascular disease, hearing loss and dementia. The genes that we carry can influence this, but it is hard to know which do, or how.
"This study increases our understanding of the genes related to ageing and ill-health and may ultimately help us to identify new treatments," said Dr Lindsay Wilson, programme manager for Genetics and Genomics at the MRC.
Age is a risk factor for many conditions, including diabetes, cardiovascular disease, hearing loss, dementia and others, but the genes that we carry also influence whether we are more or less susceptible to these.
Not much is known about which genes influence age-related conditions, or how they do so.
To explore this further, researchers from MRC introduced new mutations at random positions in the genes of mice before they were born, and then monitored their health as they aged.
If an age-related condition developed, the researchers investigated which particular gene in that mouse had been mutated.
One gene identified in this way was Slc4a10.
This was already known to be needed for eye function, but this new study linked defective Slc4a10 to age-related hearing loss for the first time, 'Science 2.0' reports.
Identifying this gene and others related to late-onset conditions in mice could now prompt investigation of the same genes in humans to ask if naturally-occurring mutations in them cause similar effects.
In future, screening people for defects in the genes identified could help to predict their chances of developing a particular condition, and the findings may one day inform treatment development or timing of interventions.
Disclaimer: No Business Standard Journalist was involved in creation of this content
